Fig. 2From: Efficacy and usability of a novel nebulizer targeting both upper and lower airwaysSubjective evaluation (a) Subjective patient’s evaluation of the use of the A3C nebulizer in 39 rhinitic patients and in 38 asthmatic patients. A response between 1 and 4 in a Visual Analogue Scale from 1 to 10 was considered as positive. b Doctor’s evaluation of the use of the A3C nebulizer in 39 rhinitic patients and in 38 asthmatic patientsBack to article page